Pioglitazone
AD-4833/TOMM40_301
Phase 3 small_molecule terminated
Quick answer
Pioglitazone for Mild Cognitive Impairment Due to Alzheimer's Disease is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated